In this target trial emulation study, the authors evaluate effectiveness of nirmatrelvir/ritonavir in non-hospitalized paediatric patients aged 12–17 years with SARS-CoV-2 Omicron infection and show reduced risks of 28 day all-cause mortality or hospitalization associated with the treatment.
All Keywords
【저자키워드】 SARS-CoV-2, Epidemiology, Outcomes research, Paediatric research,
【저자키워드】 SARS-CoV-2, Epidemiology, Outcomes research, Paediatric research,